APA (7th ed.) Citation

Gandrala, D., Rajappa, S. J., Mallavarapu, K., Santa, A., Pavan Kumar, B., Pinninti, R., . . . Tyagi, A. (2026). Real‐World Safety and Efficacy of Biosimilar Trastuzumab Emtansine (T‐DM1) in HER2‐Positive Breast Cancer: A Prospective Single‐Institution Study From India. International Journal of Breast Cancer, 2026, 1. https://doi.org/10.1155/ijbc/8863217

Chicago Style (17th ed.) Citation

Gandrala, Divya, et al. "Real‐World Safety and Efficacy of Biosimilar Trastuzumab Emtansine (T‐DM1) in HER2‐Positive Breast Cancer: A Prospective Single‐Institution Study From India." International Journal of Breast Cancer 2026 (2026): 1. https://doi.org/10.1155/ijbc/8863217.

MLA (9th ed.) Citation

Gandrala, Divya, et al. "Real‐World Safety and Efficacy of Biosimilar Trastuzumab Emtansine (T‐DM1) in HER2‐Positive Breast Cancer: A Prospective Single‐Institution Study From India." International Journal of Breast Cancer, vol. 2026, 2026, p. 1, https://doi.org/10.1155/ijbc/8863217.